Viewing nowCombinationExnindong 5/160mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 201308250 · Approved 2013.07.18 · Insurance code 649806330
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
This medication is used for patients with essential hypertension for whom blood pressure control is difficult with either amlodipine or valsartan alone. It effectively lowers blood pressure and helps reduce the risk of cardiovascular diseases.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, a direct switch to this medicine may be considered if blood pressure is not controlled with monotherapy using an individual component, as follows: ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years and older: Use caution when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Do not take this medication if you are allergic to any of its ingredients, are pregnant or breastfeeding, have severe kidney or liver dysfunction, or have certain heart diseases. Patients who are sodium or volume depleted should correct this condition before taking this medication, and if hypotension occurs during use, they should be positioned flat and receive fluid treatment if necessary. Patients with high potassium levels should be cautious when taking this medication along with potassium-raising drugs and should frequently monitor their blood potassium levels. Patients with issues related to renal vessels or who have recently undergone kidney transplantation should carefully monitor renal function while taking this medication. If signs of angioedema occur during treatment, discontinue the medication immediately and do not take it again. Patients with heart failure or after myocardial infarction should closely monitor renal function while taking this medication, and special care may be required in certain heart disease patients. When taken with other antihypertensives, this medication can lead to decreased blood pressure, hyperkalemia, and renal impairment, so blood pressure and kidney function should be frequently monitored as directed by a physician. Dizziness or fatigue may occur while driving or operating machinery, so caution is advised. Overdosing on this medication can result in severe hypotension or arrhythmias, so immediate medical attention is necessary in the case of an overdose. The safety and efficacy of this medication have not been established for children under 18 years of age, so its use is not recommended. Elderly patients may take the normal dose but should be carefully monitored for their physical condition. Women who are pregnant, planning to become pregnant, or breastfeeding should not take this medication, and should consult a physician if there is a possibility of pregnancy.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is advised to maintain storage temperatures between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a long time.
Yellowish-brown oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.